Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
US7667018B2 · kind B2 · utility
10Cited by
6References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 19, 2007 |
| Grant date | Feb 23, 2010 |
| Priority date | — |
| Expiry date | Jan 26, 2027 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A novel gene 0161P2F10B (also designated 161P2F10B) and its encoded protein, and variants thereof, are described wherein 161P2F10B exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 161P2F10B provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 161P2F10B gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 161P2F10B can be used in active or passive immunization.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.